Risk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinoma

被引:175
作者
Hirokawa, Fumitoshi [1 ]
Hayashi, Michihiro [1 ]
Asakuma, Mitsuhiro [1 ]
Shimizu, Tetsunosuke [1 ]
Inoue, Yoshihiro [1 ]
Uchiyama, Kazuhisa [1 ]
机构
[1] Osaka Med Coll, Dept Gen & Gastroenterol Surg, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan
来源
SURGICAL ONCOLOGY-OXFORD | 2016年 / 25卷 / 01期
关键词
Early recurrence; Hepatocellular carcinoma; Indocyanine green retention rate at 15 min; ICGR15; Microvascular invasion; Treatment strategy; CANCER STEM-CELLS; INTRAHEPATIC RECURRENCE; LIVER-CANCER; INTERFERON-ALPHA; RANDOMIZED-TRIAL; RESECTION; PROGNOSIS; EXPRESSION; PREVENTION; SURVIVAL;
D O I
10.1016/j.suronc.2015.12.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background: Hepatocellular carcinoma (HCC) often recurs after curative hepatectomy; and early recurrence after hepatectomy (ERAH) is associated with poor prognosis. This study aimed to clarify risk factors and disease patterns for ERAH. Methods: We retrospectively analyzed clinicopathological factors of 232 patients who underwent initial curative hepatectomies for HCC between April 2000 and March 2013, and examined associated risk factors and early recurrence patterns by liver function status (as indicated by indocyanine green retention rate at 15 min [ICGR15]). Results: Patients who experienced recurrence within 6 months after hepatectomy (i.e., ERAH) had significantly shorter survival than those with longer disease-free intervals (P < 0.001). In multivariate analysis, microvascular invasion (mVI; P = 0.034) and ICGR15 >= 16% (P = 0.010) were independent risk factors for ERAH. In the ICGR1<16% subgroup, positive L3-AFP (P = 0.04), tumor size >= 5 cm (P = 0.011), surgical margin = 0 (P = 0.0103), mVI (P = 0.034), and extrahepatic recurrence were significant predictors of ERAH; in the ICGR15 > 16%, subgroup, multiple tumors (P = 0.046) were identified as a risk factor for ERAH; however, this group did not experience much extrahepatic recurrence. Conclusions: ERAH was associated with mVI and ICGR15 >= 16%. Recurrence patterns and risk factors vary by liver function status, which should be considered in forming management strategies for early recurrence of HCC after curative hepatectomy. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:24 / 29
页数:6
相关论文
共 32 条
[1]
Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma [J].
Boucher, E ;
Corbinais, S ;
Rolland, Y ;
Bourguet, P ;
Guyader, D ;
Boudjema, K ;
Meunier, B ;
Raoul, JL .
HEPATOLOGY, 2003, 38 (05) :1237-1241
[2]
Interferon-β is more potent than interferon-α in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs [J].
Damdinsuren, B ;
Nagano, H ;
Sakon, M ;
Kondo, M ;
Yamamoto, T ;
Umeshita, K ;
Dono, K ;
Nakamori, S ;
Monden, M .
ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (10) :1184-1190
[3]
Davis A J, 2000, Lancet Oncol, V1, P86, DOI 10.1016/S1470-2045(00)00019-X
[4]
Predictor for Histological Microvascular Invasion of Hepatocellular Carcinoma: A Lesson from 229 Consecutive Cases of Curative Liver Resection [J].
Eguchi, Susumu ;
Takatsuki, Mitsuhisa ;
Hidaka, Masaaki ;
Soyama, Akihiko ;
Tomonaga, Tetsuo ;
Muraoka, Izumi ;
Kanematsu, Takashi .
WORLD JOURNAL OF SURGERY, 2010, 34 (05) :1034-1038
[5]
Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival [J].
Endo, K ;
Terada, T .
JOURNAL OF HEPATOLOGY, 2000, 32 (01) :78-84
[6]
CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma [J].
Fan, Linni ;
He, Furong ;
Liu, Hongxiang ;
Zhu, Jin ;
Liu, Yixiong ;
Yin, Zhiyong ;
Wang, Lu ;
Guo, Ying ;
Wang, Zhe ;
Yan, Qingguo ;
Huang, Gaosheng .
BMC CANCER, 2011, 11
[7]
Prediction of Posthepatectomy Recurrence of Hepatocellular Carcinoma by Circulating Cancer Stem Cells A Prospective Study [J].
Fan, Sheung Tat ;
Yang, Zhen Fan ;
Ho, David W. Y. ;
Ng, Michael N. P. ;
Yu, Wan Ching ;
Wong, John .
ANNALS OF SURGERY, 2011, 254 (04) :569-576
[8]
Hayashi M, 2011, AM SURGEON, V77, P572
[9]
A novel method using the VIO soft-coagulation system for liver resection [J].
Hirokawa, Fumitoshi ;
Hayashi, Michihiro ;
Miyamoto, Yoshiharu ;
Iwamoto, Mitsuhiko ;
Tsunematsu, Ichiro ;
Asakuma, Mitsuhiro ;
Shimizu, Tetsunosuke ;
Komeda, Koji ;
Inoue, Yoshihiro ;
Tanigawa, Nobuhiko .
SURGERY, 2011, 149 (03) :438-444
[10]
Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor - A prospective randomized study of hepatitis C virus-related liver cancer [J].
Ikeda, K ;
Arase, Y ;
Saitoh, S ;
Kobayashi, M ;
Suzuki, Y ;
Suzuki, F ;
Tsubota, A ;
Chayama, K ;
Murashima, N ;
Kumada, H .
HEPATOLOGY, 2000, 32 (02) :228-232